NCT04907513

Brief Summary

Depression is a major public concern associated with profound distress, intense suffering, and impairment in social, professional and familial functioning. Among the numerous symptoms defining depression, fatigue and motivation are not only frequent but also highly associated with poor quality of life and resistance to conventional antidepressant. Recent data, mainly obtained in animals, suggest that these symptoms may be linked to inflammatory processes within the central nervous system. Yet access to the brain is too invasive for exploring this link in patients with psychiatric conditions. However, certain conditions in neurosurgery, such as aneurysm rupture, require external evacuation, over several days or weeks, of the fluid bathing the brain through a catheter directly inserted into it. Critically, these patients also exhibit extreme exhaustion and fluctuating motivation, allowing to investigate the involvement of neuroinflammation in lack of motivation and fatigue by carrying out repeated motivation assessments with short behavioral tests (around ten minutes), while performing an analysis of inflammation markers in the fluid evacuated from the brain. The identification of inflammatory mechanisms underlying lack of motivation and fatigue could lead to the development of treatments for both resistant depression and motivation deficits that largely hamper rehabilitation in neurosurgery.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
25

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Dec 2021

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 25, 2021

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 28, 2021

Completed
6 months until next milestone

Study Start

First participant enrolled

December 4, 2021

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 4, 2023

Completed
12 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2024

Completed
Last Updated

February 17, 2023

Status Verified

February 1, 2023

Enrollment Period

2 years

First QC Date

May 25, 2021

Last Update Submit

February 16, 2023

Conditions

Keywords

cerebrospinal fluid

Outcome Measures

Primary Outcomes (1)

  • Nerotransmitter levels in cerebrospinal fuid in relation to patient motivational condition

    Study the correlation between serotonin, dopamin and glutamate concentrations in the cerebrospinal fluid with the motivational state of the patients

    36 months

Study Arms (1)

Amotivational Syndrome

Patients required an external drainage of the cerebrospinal fluid.

Other: Assessment of the Motivational State

Interventions

A motivational interviewing algorithm developed in Rothschild Hospital for this study will be used. The results range between 0% (worst motivational state) to 100% (best motivational state).

Amotivational Syndrome

Eligibility Criteria

Age18 Years - 95 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients required an external drainage of the cerebrospinal fluid

You may qualify if:

  • Age \>= 18 years old
  • Patients required an external cerebrospinal fluid drainage

You may not qualify if:

  • Pregnant or breast feeding patient
  • Patient under legal protection
  • Patient opposition to participate in this study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hôpital Fondation Adolphe de Rothschild

Paris, Île-de-France Region, 75019, France

RECRUITING

MeSH Terms

Conditions

Brain InjuriesFatigue

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemWounds and InjuriesSigns and SymptomsPathological Conditions, Signs and Symptoms

Central Study Contacts

Pierre Bourdillon, MD, PhD

CONTACT

Amélie Yavchitz, MD,PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
NETWORK
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 25, 2021

First Posted

May 28, 2021

Study Start

December 4, 2021

Primary Completion

December 4, 2023

Study Completion

December 1, 2024

Last Updated

February 17, 2023

Record last verified: 2023-02

Locations